Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Pernix Therapeutics Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Pernix Therapeutics Holdings Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Pernix Therapeutics Holdings Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Pernix Therapeutics Holdings Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Pernix Therapeutics Holdings Inc, Medical Devices Deals, 2012 to YTD 2018 10
Pernix Therapeutics Holdings Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Pernix Therapeutics Holdings Inc, Pharmaceuticals & Healthcare, Deal Details 13
Asset Purchase 13
Pernix Therapeutics Acquires Rights to Contrave/Mysimba from Orexigen Therapeutics for USD75 Million 13
Pernix Acquires Zohydro ER Business from Zogenix 14
Pernix Therapeutics Completes Acquisition of Treximet Tablets For Migraine From GlaxoSmithKline 16
Partnerships 18
Pernix Therapeutics Enters Into Co-Promotion Agreement With Osmotica Pharma For Khedezla ER Tablets 18
Cumberland Pharma Enters Into Co-Promotion Agreement With Pernix Therapeutics 19
Somaxon Pharma Enters Into Co-Marketing Agreement With CJ CheilJedang For Silenor 20
Particle Sciences Enters Into Co-Development Agreement With Pernix Therapeutics 21
Pernix Therapeutics Enters Into Co-Development Agreement For Pediatric Product 22
Licensing Agreements 23
Pernix Therapeutics Enters into Licensing Agreement with Recro Pharma 23
Pernix Therapeutics Enters Into Licensing Agreement For Prescription Product To Treat Gastroenterology Disease 24
Equity Offering 25
Pernix Therapeutics Plans to Raise up to USD50 Million in Public Offering of Shares 25
Pernix Therapeutics Plans to Raise Funds through Public Offering of Shares 26
Pernix Therapeutics to Raise up to USD16 Million in Public Offering of Shares 27
Somaxon Pharma Completes Private Placement Of Shares For US$3 Million 28
Pernix Therapeutics Completes Public Offering Of Shares For US$21.3 Million 29
Debt Offering 31
Pernix Therapeutics Raises USD130 Million in Private Placement of 4.25% Notes Due 2021 31
Pernix Therapeutics Holdings Raises USD65 Million in Private Palcement of 8% Notes Due 2019 33
Pernix Therapeutics Holdings Raises USD220 Million in Private Placement of Notes 34
Pernix Therapeutics Completes Private Placement Of Notes Due 2019 For US$65 Million 35
Asset Transactions 36
SI Pharma Acquires Cedax from Pernix Therapeutics 36
Breckenridge Pharma Completes Acquisition of Certain Generic Assets From Pernix Therapeutics For US$30 Million 37
Acquisition 38
Pernix Therapeutics May Sell Itself 38
Woodfield Pharma Acquires Pernix Manufacturing From Pernix Therapeutics For US$6.2 Million 39
Pernix Therapeutics Completes Acquisition Of Somaxon Pharma For US$25 Million 40
Pernix Therapeutics Completes Acquisition Of Cypress Pharma And Hawthorn Pharma For US$102 Million 42
Pernix Therapeutics Completes Acquisition Of Great Southern Laboratories For US$6 Million 43
Pernix Therapeutics Holdings Inc – Key Competitors 44
Pernix Therapeutics Holdings Inc – Key Employees 45
Pernix Therapeutics Holdings Inc – Locations And Subsidiaries 46
Head Office 46
Other Locations & Subsidiaries 46
Recent Developments 47
Financial Announcements 47
Aug 09, 2018: Pernix Therapeutics reports second quarter 2018 financial results 47
May 10, 2018: Pernix Therapeutics Reports First Quarter 2018 Financial Results 50
Mar 08, 2018: Pernix Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results 51
Nov 07, 2017: Pernix Therapeutics Reports Third Quarter 2017 Financial Results 54
Jul 27, 2017: Pernix Therapeutics Reports Second Quarter 2017 Financial Results and Provides Business Update 57
Jul 20, 2017: Pernix Therapeutics Pre-Announces Certain Preliminary Second Quarter 2017 Financial Results 60
May 15, 2017: Pernix Therapeutics Reports First Quarter 2017 Financial Results and Provides Business Update 62
Mar 28, 2017: Pernix Therapeutics Announces Fourth Quarter And Full Year 2016 Financial Results 64
Corporate Communications 68
Feb 06, 2018: Pernix Announces Appointment of Lead Independent Director and Key Management Team Promotion 68
Nov 16, 2017: Pernix Therapeutics Announces Election of Two Healthcare Industry Veterans to Board of Directors 69
Oct 17, 2017: Pernix Therapeutics Announces Planned Departure of Chief Financial Officer 70
Appendix 71
Methodology 71
About GlobalData 71
Contact Us 71
Disclaimer 71
Pernix Therapeutics Holdings Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Pernix Therapeutics Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Pernix Therapeutics Holdings Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Pernix Therapeutics Holdings Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Pernix Therapeutics Holdings Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Pernix Therapeutics Holdings Inc, Medical Devices Deals, 2012 to YTD 2018 10
Pernix Therapeutics Holdings Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Pernix Therapeutics Acquires Rights to Contrave/Mysimba from Orexigen Therapeutics for USD75 Million 13
Pernix Acquires Zohydro ER Business from Zogenix 14
Pernix Therapeutics Completes Acquisition of Treximet Tablets For Migraine From GlaxoSmithKline 16
Pernix Therapeutics Enters Into Co-Promotion Agreement With Osmotica Pharma For Khedezla ER Tablets 18
Cumberland Pharma Enters Into Co-Promotion Agreement With Pernix Therapeutics 19
Somaxon Pharma Enters Into Co-Marketing Agreement With CJ CheilJedang For Silenor 20
Particle Sciences Enters Into Co-Development Agreement With Pernix Therapeutics 21
Pernix Therapeutics Enters Into Co-Development Agreement For Pediatric Product 22
Pernix Therapeutics Enters into Licensing Agreement with Recro Pharma 23
Pernix Therapeutics Enters Into Licensing Agreement For Prescription Product To Treat Gastroenterology Disease 24
Pernix Therapeutics Plans to Raise up to USD50 Million in Public Offering of Shares 25
Pernix Therapeutics Plans to Raise Funds through Public Offering of Shares 26
Pernix Therapeutics to Raise up to USD16 Million in Public Offering of Shares 27
Somaxon Pharma Completes Private Placement Of Shares For US$3 Million 28
Pernix Therapeutics Completes Public Offering Of Shares For US$21.3 Million 29
Pernix Therapeutics Raises USD130 Million in Private Placement of 4.25% Notes Due 2021 31
Pernix Therapeutics Holdings Raises USD65 Million in Private Palcement of 8% Notes Due 2019 33
Pernix Therapeutics Holdings Raises USD220 Million in Private Placement of Notes 34
Pernix Therapeutics Completes Private Placement Of Notes Due 2019 For US$65 Million 35
SI Pharma Acquires Cedax from Pernix Therapeutics 36
Breckenridge Pharma Completes Acquisition of Certain Generic Assets From Pernix Therapeutics For US$30 Million 37
Pernix Therapeutics May Sell Itself 38
Woodfield Pharma Acquires Pernix Manufacturing From Pernix Therapeutics For US$6.2 Million 39
Pernix Therapeutics Completes Acquisition Of Somaxon Pharma For US$25 Million 40
Pernix Therapeutics Completes Acquisition Of Cypress Pharma And Hawthorn Pharma For US$102 Million 42
Pernix Therapeutics Completes Acquisition Of Great Southern Laboratories For US$6 Million 43
Pernix Therapeutics Holdings Inc, Key Competitors 44
Pernix Therapeutics Holdings Inc, Key Employees 45
Pernix Therapeutics Holdings Inc, Subsidiaries 46
List of Figures
Pernix Therapeutics Holdings Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Pernix Therapeutics Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Pernix Therapeutics Holdings Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Pernix Therapeutics Holdings Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Pernix Therapeutics Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Pernix Therapeutics Holdings Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Pernix Therapeutics Holdings Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Pernix Therapeutics Holdings Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Pernix Therapeutics Holdings Inc, Medical Devices Deals, 2012 to YTD 2018 10
【免責事項】
http://www.globalresearch.jp/disclaimer